Andrew Mulberg, MD, has entered into a consulting agreement with Jaguar Health, a pharmaceutical company developing prescription medicines for gastrointestinal distress.
Dr. Mulberg previously spent six years as deputy director of the division of gastroenterology and inborn errors products for the FDA, according to a Jan. 30 release. He currently serves as senior vice president of regulatory affairs for Neurogene.
Dr. Mulberg is also chair of the medical advisory board for the Go4 the Goal Foundation, a pediatric cancer advocacy nonprofit. He teaches as an adjunct professor of pediatrics at the University of Maryland Medical Center in Baltimore.